Navigation Links
Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
Date:11/13/2012

HAYWARD, Calif., Nov. 13, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced additional data from its Phase 2b PEARL-SC study presented in a late breaking poster at the 2012 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals (ACR/ARHP). The poster entitled "Blisibimod, an Inhibitor of B cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus," was presented by Dr. Richard Furie, MD, on Tuesday, November 13, 2012. Dr. Furie is Chief of the Division of Rheumatology and Allergy-Clinical Immunology at the North Shore-Long Island Jewish Health System and directs the hospital's Systemic Lupus Erythematosus (SLE) and Autoimmune Disease Treatment Center.

The poster highlights data from the PEARL-SC clinical study including new information regarding treatment effects in the broader modified intent to treat population of lupus patients where 200 mg weekly blisibimod therapy was associated with statistically significant benefits in predefined SLE Responder Index (SRI*) endpoints. Specifically, this new data indicates statistically significant treatment effects using higher thresholds of improvement in disease score (SELENA/SLEDAI** reductions of 7 and 8) including the recently FDA reviewed SRI-8 endpoint to be utilized in the phase 3 CHABLIS-SC clinical studies. These data confirm and expand on previously reported clinical improvements seen in the population of patients to be enrolled in the CHABLIS-SC phase 3 clinical studies. These studies will enroll patients with active disease (SELENA/SLEDAI > 10) who are also receiving corticosteroid therapy at baseline.

As well, the poster highlighted the positive effect
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
2. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
3. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
4. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
5. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
7. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
8. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
9. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
10. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
11. Anthera Announces First Quarter 2012 Financial Report and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 ... the addition of the  "2015 Strategies in ...  report to their offering.       ... report contains 500 pages, 120 tables, and ... potential market entrants identify and evaluate business ...
(Date:5/27/2015)... YORK , May 27, 2015 PharmaPoint: Type ... 2023 Summary Type 1 diabetes (T1D) is an ... islet, which means that the body can no longer produce ... evolving continuously, as at present, no other treatment can be ... A variety of insulin analogs with different times of action ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
Breaking Medicine Technology:European Hemostasis Diagnostic Testing Market Strategies 2015 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4United States Nucleic Acid Testing Market Strategies 2015-2020 2
... Nov. 30, 2011  VR Laboratories LLC has hired nutritional ... sales and marketing director. Hall will apply his 30 ... the VR Laboratories brand and to launch new company ... http://photos.prnewswire.com/prnh/20111130/FL14815 ) "Tom,s extensive ...
... leading biopharmaceutical company committed to the development of new ... key sets of Vimpat® (lacosamide) C-V data at the ... in Baltimore, Md., December 2-6.  "At ... lives of people living with epilepsy," said Dr. James ...
Cached Medicine Technology:Tom Hall Named National Sales and Marketing Director for VR Laboratories 2Tom Hall Named National Sales and Marketing Director for VR Laboratories 3New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 2New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 3New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 4New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 5New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 6New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 7
(Date:5/27/2015)... Western University of Health Sciences’ 34th ... firsts -- and one profound last. , The May ... the first time the university surpassed more than 1,000 ... College of Biomedical Sciences (GCBS) alumnus graduated from the ... The university’s fifth and final ceremony of its three-day ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The BBB ... customer service practices that enhance customer trust and confidence ... Standards for Trust, eight principles that summarize important elements ... also represents standards for business accreditation by BBB. Businesses ... these standards and complete application procedures will be accredited ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Continuing its ... of healthier patients in the community, SmartPractice® ... (formerly John C. Lincoln). SmartPractice Vice President of Human ... Shaw presented a $25,000 check to Paulla Miller, Sherry ... Breast Health & Research Center on April 30. The ...
(Date:5/27/2015)... Marcos, CA (PRWEB) May 27, 2015 Allred ... solution to help patients - who need extensive dental treatment ... well as treatment options customized for their problems. , Dr. ... in a visual presentation of the assessment of the patient’s ... suitable options, which can treat their oral health problems. , ...
(Date:5/27/2015)... 27, 2015 Black Book Rankings, ... surveys in the multiple services and software industries, ... the highest ranked Electronic Health and Medical Record ... special research focus on implemented EHR users, Black ... vendors with the highest scores in client experience ...
Breaking Medicine News(10 mins):Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4
... RGDX ) today announced its President and CEO, ... on its ERCC-1,molecular diagnostic gene expression test for cisplatin-based ... Diego Marriot Del,Mar in San Diego October 31 to ... Thursday, Nov. 1. The presentation will be made ...
... NOGALES, Mexico, Oct. 31 Consejo de Latinos ... educates and,assists Latinos and others, and government officials ... news conference today the launch of an,international investigative ... 1st. Immigrant "dumping" is the practice of ...
... Provides Customized Oral Chemotherapy ... ... Maximizing on the momentum gained,during Breast Cancer Awareness Month, healthcare ... cancer patients --,OralChemoAdvisor.com -- an educational, state-of-the-art Web site about,oral ...
... shows that massage therapy decreases pain levels for patients after heart ... participated in a pilot study to examine the effect of massage ... mean pain scores were less than 1 on a scale of ... the massage therapy, these patients rated their pain at an average ...
... 31 Impact,Medical Solutions, Inc. (OTC Bulletin Board: ... of Craig W. Lunsman to its board,of directors. ... of William,Jamieson Group, LLC, a consulting group that ... and private small cap companies.,As an outside director, ...
... Top-Ranked Medicaid Plan in Pennsylvania, PITTSBURGH, Oct. 31 ... for Quality Assurance (NCQA) recently released its third,report on ... Plans 2007."* Gateway Health Plan is ranked #12 among ... in Pennsylvania. "Gateway Health Plan is extremely proud ...
Cached Medicine News:Health News:Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference 2Health News:Latino Advocacy Group Investigates Immigrant 'Dumping' by U.S. Employers 2Health News:Roche Offers Innovative Website Designed to Empower Cancer Patients 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 3Health News:Impact Medical Solutions Announces Appointment of New Director 2Health News:Impact Medical Solutions Announces Appointment of New Director 3Health News:Gateway Health Plan Ranked Again Among 'America's Best Health Plans' According to U.S. News & World Report, NCQA 2
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 20-200 Inaccuracy (%) ... Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: